Dashboard › Demo Universe › Summit Chemical

Summit Chemical · SMCH

DEMO DATAUNDERWRITING ASSUMPTIONPASS

Return analysis — Senior Unsecured Notes 5.75%

HYPOTHETICAL INVESTMENT TERMSUNDERWRITING ASSUMPTION
Face value
$100.0M
Purchase price (assumption)
92.0
Cash investment
$92.5M
Current yield
6.3%
Yield to maturity
9.5%
Base CaseDownsideSevere DownsideExpected
OutcomePerformingDefault (FY2028E)Default (FY2027E)
Face value (legal claim)$100.0M$100.0M$100.0M
Purchase price → cash investment92.0 → $92.5M92.0 → $92.5M92.0 → $92.5M
Cash interest received$11.5M$17.3M$11.5M
Exit price (performing) / recovery proceeds (default)100.0 → $100.0M$67.3M$16.5M
Capital gain / (loss) vs purchase price$8.0M($24.7M)($75.5M)
Total cash proceeds$111.5M$84.5M$28.0M
Valuation recovery % · loss given default100% · 0%66% · 34%16% · 84%
Absolute profit$19.0M($7.9M)($64.5M)
MOIC1.21x0.91x0.30x0.98x
IRR (annual periods)10.1%-2.5%-37.8%-0.7%
IRR (contractual timing, 1x/yr coupons)10.1%-2.5%-37.8%-0.7%
Scenario probability55%30%15%
Required return (hurdle IRR) → statusFAIL 12%FAIL 12%FAIL 12%FAIL
Probability-weighted expected loss
45% P(default) × 50% LGD = 22.7%
Max entry price that still earns the hurdle (base case)
89.0 vs assumed 92.0
Recovery needed for MOIC 1.0x if default
75% of face

Expected column = IRR of the probability-weighted cash flows (-0.7%), not the average of scenario IRRs (-0.8%); IRR is non-linear. Contractual timing re-times the same coupon dollars to 1 payment(s) per year (settlement on a coupon date, no accrued interest); principal/recovery stay on annual dates. Fees: 0.5% of cost, paid at t=0. Per $100M face. Timing: coupons at period ends; default → recovery cash 1 period after the default period; performing exit at the hold period at the lesser of the scenario exit-price cap and valuation coverage at the exit multiple. Floating coupons include the scenario rate shock. Scenario weights 55% / 30% / 15%.

Sensitivity analysis — where is the risk / return attractive?

Sensitivity 1 — Purchase price vs IRR

Purchase price (% of face)Base CaseDownsideSevere Downside
84.015.4%0.0%-35.6%
88.012.6%-1.3%-36.7%
92.010.1%-2.5%-37.8%
96.07.7%-3.6%-38.8%
100.05.5%-4.7%-39.7%

Sensitivity 2 — Exit / recovery value (% of face) vs IRR

Proceeds (% of face)Base CaseDownsideSevere Downside
20.0-44.0%-24.5%-34.3%
40.0-26.5%-12.9%-19.4%
60.0-12.5%-4.9%-8.9%
80.0-0.5%1.4%-0.4%
100.010.1%6.7%6.8%

Sensitivity 3 — EBITDA margin shift vs IRR (full model re-run)

EBITDA margin shiftBase CaseDownsideSevere Downside
-4.0 pts10.1%-11.5%-51.7%
-2.0 pts10.1%-9.2%-43.3%
+0.0 pts10.1%-2.5%-37.8%
+2.0 pts10.1%7.0%-37.8%
+4.0 pts10.1%4.9%-25.4%

Sensitivity 4 — Revenue growth shift vs IRR (full model re-run)

Revenue growth shiftBase CaseDownsideSevere Downside
-10.0 pts10.1%-1.2%-37.8%
-5.0 pts10.1%-1.6%-37.8%
+0.0 pts10.1%-2.5%-37.8%
+5.0 pts10.1%2.2%-39.4%
+10.0 pts10.1%4.9%-41.9%

Sensitivity 5 — Interest rate (SOFR) shift vs IRR (full model re-run)

SOFR shiftBase CaseDownsideSevere Downside
-1.0 pts10.1%-1.5%-37.4%
-0.5 pts10.1%-2.0%-37.6%
+0.0 pts10.1%-2.5%-37.8%
+1.0 pts10.1%-3.5%-38.8%
+2.0 pts10.1%-4.7%-40.7%

Sensitivity 6 — Distressed valuation multiple shift vs target-tranche recovery %

Multiple shift (x EBITDA)Base CaseDownsideSevere Downside
-2.0x100.0%66.3%16.3%
-1.0x100.0%66.3%16.3%
+0.0x100.0%66.3%16.3%
+1.0x100.0%91.2%16.3%
+2.0x100.0%100.0%16.3%

Sensitivity 7 — Recovery / exit value (% of face) vs MOIC

Proceeds (% of face)Base CaseDownsideSevere Downside
20.00.34x0.40x0.34x
40.00.56x0.62x0.56x
60.00.77x0.84x0.77x
80.00.99x1.05x0.99x
100.01.21x1.27x1.21x

Green ≥ hurdle IRR (12%) · amber = positive but below hurdle · red = loss (recovery table: green = full recovery, amber ≥ 60%). Every cell is the same calculation as the Excel Sensitivities tab; margin, growth, rate and multiple tables re-run the entire model (statements → debt → default → recovery → returns).

Return calculator

Face value (legal claim)$100.0M
Cash investment (face × price × (1 + fees))$92.5M
Current yield (coupon ÷ price)6.3%
Cash interest received$11.5M
Exit / recovery proceeds$100.0M
Capital gain / (loss) vs purchase price$8.0M
Total cash proceeds$111.5M
Absolute profit$19.0M
MOIC1.21x
IRR10.1%